192 related articles for article (PubMed ID: 28410232)
1. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP.
Sander P; Mostafa H; Soboh A; Schneider JM; Pala A; Baron AK; Moepps B; Wirtz CR; Georgieff M; Schneider M
Oncotarget; 2017 May; 8(21):35124-35137. PubMed ID: 28410232
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TRPM7 with waixenicin A reduces glioblastoma cellular functions.
Wong R; Gong H; Alanazi R; Bondoc A; Luck A; Sabha N; Horgen FD; Fleig A; Rutka JT; Feng ZP; Sun HS
Cell Calcium; 2020 Dec; 92():102307. PubMed ID: 33080445
[TBL] [Abstract][Full Text] [Related]
4. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
[TBL] [Abstract][Full Text] [Related]
5. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
Liu M; Inoue K; Leng T; Guo S; Xiong ZG
Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TRPM7 with carvacrol suppresses glioblastoma functions in vivo.
Alanazi R; Nakatogawa H; Wang H; Ji D; Luo Z; Golbourn B; Feng ZP; Rutka JT; Sun HS
Eur J Neurosci; 2022 Mar; 55(6):1483-1491. PubMed ID: 35277895
[TBL] [Abstract][Full Text] [Related]
7. Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.
Wong R; Turlova E; Feng ZP; Rutka JT; Sun HS
Oncotarget; 2017 Feb; 8(7):11239-11248. PubMed ID: 28061441
[TBL] [Abstract][Full Text] [Related]
8. Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.
Chen WL; Turlova E; Sun CL; Kim JS; Huang S; Zhong X; Guan YY; Wang GL; Rutka JT; Feng ZP; Sun HS
Mar Drugs; 2015 Apr; 13(4):2505-25. PubMed ID: 25913706
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.
Kitambi SS; Toledo EM; Usoskin D; Wee S; Harisankar A; Svensson R; Sigmundsson K; Kalderén C; Niklasson M; Kundu S; Aranda S; Westermark B; Uhrbom L; Andäng M; Damberg P; Nelander S; Arenas E; Artursson P; Walfridsson J; Forsberg Nilsson K; Hammarström LGJ; Ernfors P
Cell; 2014 Apr; 157(2):313-328. PubMed ID: 24656405
[TBL] [Abstract][Full Text] [Related]
10. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma.
Li Z; Mbah NE; Overmeyer JH; Sarver JG; George S; Trabbic CJ; Erhardt PW; Maltese WA
BMC Cancer; 2019 Jan; 19(1):77. PubMed ID: 30651087
[TBL] [Abstract][Full Text] [Related]
11. TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury.
Chen W; Xu B; Xiao A; Liu L; Fang X; Liu R; Turlova E; Barszczyk A; Zhong X; Sun CL; Britto LR; Feng ZP; Sun HS
Mol Brain; 2015 Feb; 8():11. PubMed ID: 25761704
[TBL] [Abstract][Full Text] [Related]
12. Carvacrol affects breast cancer cells through TRPM7 mediated cell cycle regulation.
Li L; He L; Wu Y; Zhang Y
Life Sci; 2021 Feb; 266():118894. PubMed ID: 33310045
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.
Hayashi K; Michiue H; Yamada H; Takata K; Nakayama H; Wei FY; Fujimura A; Tazawa H; Asai A; Ogo N; Miyachi H; Nishiki T; Tomizawa K; Takei K; Matsui H
Sci Rep; 2016 Mar; 6():23372. PubMed ID: 26988603
[TBL] [Abstract][Full Text] [Related]
14. The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features.
Hammarström LG; Harmel RK; Granath M; Ringom R; Gravenfors Y; Färnegårdh K; Svensson PH; Wennman D; Lundin G; Roddis Y; Kitambi SS; Bernlind A; Lehmann F; Ernfors P
J Med Chem; 2016 Sep; 59(18):8577-92. PubMed ID: 27607569
[TBL] [Abstract][Full Text] [Related]
15. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.
Zhou W; Guo S; Xiong Z; Liu M
Expert Opin Ther Targets; 2014 Oct; 18(10):1177-96. PubMed ID: 25069584
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
[TBL] [Abstract][Full Text] [Related]
18. The soft underbelly of tumor cells.
Shi Y; Lim SK; Parada LF
Cell Res; 2014 Aug; 24(8):910-1. PubMed ID: 24874955
[TBL] [Abstract][Full Text] [Related]
19. A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors.
El Meskini R; Iacovelli AJ; Kulaga A; Gumprecht M; Martin PL; Baran M; Householder DB; Van Dyke T; Weaver Ohler Z
Dis Model Mech; 2015 Jan; 8(1):45-56. PubMed ID: 25431423
[TBL] [Abstract][Full Text] [Related]
20. The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas.
Held-Feindt J; Schmelz S; Hattermann K; Mentlein R; Mehdorn HM; Sebens S
Neurochem Int; 2012 Dec; 61(7):1183-91. PubMed ID: 22948185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
